PMC:7558914 / 18854-19097
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 446 | 49-80 | Chemical | denotes | hydroxychloroquine-azithromycin | |
| 447 | 103-122 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 460 | 9-18 | Disease | denotes | pneumonia | MESH:D011014 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T33 | 9-18 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T123 | 0-243 | Sentence | denotes | For mild pneumonia, dual therapies consisting of hydroxychloroquine-azithromycin or hydroxychloroquine-lopinavir/ritonavir were the most frequent treatments recommended, with regimens that included different dosages and durations of treatment. |